-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA APPROVAL OF EDWARDS LIFESCIENCES’ PASCAL PRECISION SYSTEM OPENS NEW TREATMENT PATHWAY FOR PATIENTS WITH TRICUSPID VALVE DISEASE

Reuters·10/21/2026 13:00:03

Please log in to view news